Status:
COMPLETED
Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Giant Cell Arteritis
Eligibility:
All Genders
18+ years
Brief Summary
Giant cell arteritis (GCA) is the most common vasculitis in adults. The diagnosis of GCA is evoked by the association of clinical signs and biological anomalies (inflammatory syndrome) in patients ove...
Eligibility Criteria
Inclusion
- Any patient for which the diagnosis of GCA is suspected and who underwent a cervical PET/CT
Exclusion
- previously diagnosed GCA, glycemia \> 7 mmol/L, PET CT performed more than 72 h after introduction of glucocorticoids, age \< 50 years
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05246540
Start Date
January 1 2020
End Date
December 1 2021
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000